Disseminated Herpes Simplex Virus Type 2 after Treatment with Idelalisib

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 14, Issue 3

Abstract

Introduction: Case reports describing disseminated Herpes simplex virus type 2 (HSV-2) disease are limited. To our knowledge, this is the first report of disseminated HSV-2 infection in a patient who was treated by idelalisib.Case: A 62-year-old female with chronic lymphocytic leukemia (CLL) presented with a painful pruritic rash. Her skin exam showed multiple erythematous papular lesions with central necrosis. Polymerase chain reaction in the peripheral blood and skin lesions was positive for HSV-2. The diagnosis of idelalisib-associated disseminated HSV-2 was made and the patient was started on IV acyclovir. On follow-up, her skin lesions completely resolved in six weeks. Idelalisib was stopped and the patient was started on venetoclax. Discussion: Idelalisib is a highly specific phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor that was approved by the FDA for the treatment of relapsed chronic lymphocytic leukemia, in combination with rituximab, relapsed follicular B-cell non-Hodgkin lymphoma, and in relapsed small lymphocytic lymphoma. This case highlights the potential cutaneous manifestation in immunocompromised individuals, which is often atypical and poses a difficulty in diagnosis. Physicians should consider HSV-2 as a rare but important cause of a disseminated rash in immunocompromised individuals. Antivirals including acyclovir and valacyclovir can successfully treat HSV-2 associated skin infection.

Authors and Affiliations

Joseph Attallah, Uqba Khan, Mamta Sharma, Zyad Kafri

Keywords

Related Articles

Current Recommendations on Treatment of Acute Diverticulitis – Mini Review

Diverticulosis is a common disease in Western world and is associated with a Western lifestyle with low fiber diet, smoking, constipation. It is quite rare in the East, however it’s incidence is growing also in the Easte...

Probiotics for Health Benefits: The Regulatory Concerns and Suggestive Roadmap

Probiotics, the friendly bugs, has gained impressive attention worldwide due to their nutraceutical and pharmaceutical benefits, established in recent years. However existing regulatory regime in various countries has am...

Effects of Supplementation with Glutathione and its Precursors on Athlete Performance

Glutathione (GSH) is a thiol-containing tripeptide consisting of glutamate (Glu), cysteine (Cys) and glycine (Gly), which plays central roles in the defense against oxidative damage and in signaling pathways. The cellula...

Reactive Oxygen Species Over Production and Superoxide Dismutase Exhaustion Promoting the Intervertebral Disc Degeneration

Background: Oxidative overstress is realized as one of the most prevalent causes of Intervertebral Disc Degeneration (IVDD) by restraining the metabolism and damaging the cell matrix, but the specific process i...

Some Actions to Alleviate Symptoms of Autism

A mini review has been performed regarding the causes of autism. There are genetic factors and environmental factors. With the objective of helping parents of autistic children, this work has presented many categories of...

Download PDF file
  • EP ID EP585900
  • DOI 10.26717/BJSTR.2019.14.002560
  • Views 121
  • Downloads 0

How To Cite

Joseph Attallah, Uqba Khan, Mamta Sharma, Zyad Kafri (2019). Disseminated Herpes Simplex Virus Type 2 after Treatment with Idelalisib. Biomedical Journal of Scientific & Technical Research (BJSTR), 14(3), 10700-10702. https://europub.co.uk/articles/-A-585900